Log in
Enquire now
HiberCell

HiberCell

HiberCell is a New York-based biotechnology company developing therapeutics to prevent relapse and metastasis.

OverviewStructured DataIssuesContributors
Is a
Organization
Organization
Company
Company
B2X
B2B
B2B
0
Company Operating Status
Active
Country
United States
United States
Crunchbase URL
crunchbase.com/organiz...ibercell
Founded Date
2019
Founder
‌
Alan Rigby, Ph.D.
‌
Ari Nowacek, M.D., Ph.D.
‌
Julio Aguirre-Ghiso, Ph.D.
Full Address
619 West 54th Street, 8th Floor, New York, New York 10019, US
0
Industry
Oncology
Oncology
Engineering
Engineering
Cancer
Cancer
Therapeutics
Therapeutics
Medical diagnostics
Medical diagnostics
Biomedical engineering
Biomedical engineering
Biotechnology
Biotechnology
Internal medicine
Internal medicine
Healthcare
Healthcare
Medicine
Medicine
•••
Investors
Bristol-Myers Squibb
Bristol-Myers Squibb
ARCH Venture Partners
ARCH Venture Partners
Latest Funding Round Date
May 19, 2021
Latest Funding Type
Series B
Series B
LinkedIn URL
@company/hibercell
Location
New York City
New York City
New York
New York
Number of Employees (Ranges)
51 – 200
0
Patents Assigned (Count)
1
Total Funding Amount (USD)
128,150,000
Official Website
hibercell.com

Find more companies like HiberCell

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.